vs
Side-by-side financial comparison of CuriosityStream Inc. (CURI) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Entrada Therapeutics, Inc. is the larger business by last-quarter revenue ($20.6M vs $19.2M, roughly 1.1× CuriosityStream Inc.). CuriosityStream Inc. runs the higher net margin — -19.7% vs -84.4%, a 64.7% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs -65.2%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $-39.7M). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs 6.4%).
Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
CURI vs TRDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $20.6M |
| Net Profit | $-3.8M | $-17.3M |
| Gross Margin | — | — |
| Operating Margin | -17.6% | -106.0% |
| Net Margin | -19.7% | -84.4% |
| Revenue YoY | 35.8% | -65.2% |
| Net Profit YoY | -34.6% | -173.8% |
| EPS (diluted) | $-0.07 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | — | ||
| Q3 25 | $18.4M | — | ||
| Q2 25 | $19.0M | — | ||
| Q1 25 | $15.1M | $20.6M | ||
| Q4 24 | $14.1M | $37.4M | ||
| Q3 24 | $12.6M | $19.6M | ||
| Q2 24 | $12.4M | $94.7M | ||
| Q1 24 | $12.0M | $59.1M |
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $-3.7M | — | ||
| Q2 25 | $784.0K | — | ||
| Q1 25 | $319.0K | $-17.3M | ||
| Q4 24 | $-2.8M | $1.1M | ||
| Q3 24 | $-3.1M | $-14.0M | ||
| Q2 24 | $-2.0M | $55.0M | ||
| Q1 24 | $-5.0M | $23.5M |
| Q4 25 | -17.6% | — | ||
| Q3 25 | -24.5% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 0.5% | -106.0% | ||
| Q4 24 | -27.4% | -15.7% | ||
| Q3 24 | -25.8% | -110.7% | ||
| Q2 24 | -20.6% | 56.4% | ||
| Q1 24 | -30.4% | 35.7% |
| Q4 25 | -19.7% | — | ||
| Q3 25 | -20.4% | — | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | 2.1% | -84.4% | ||
| Q4 24 | -19.9% | 3.0% | ||
| Q3 24 | -24.3% | -71.7% | ||
| Q2 24 | -16.4% | 58.1% | ||
| Q1 24 | -42.0% | 39.7% |
| Q4 25 | $-0.07 | — | ||
| Q3 25 | $-0.06 | — | ||
| Q2 25 | $0.01 | — | ||
| Q1 25 | $0.01 | $-0.42 | ||
| Q4 24 | $-0.05 | $-0.20 | ||
| Q3 24 | $-0.06 | $-0.35 | ||
| Q2 24 | $-0.04 | $1.55 | ||
| Q1 24 | $-0.09 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $27.3M | $67.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $41.5M | $417.3M |
| Total Assets | $75.7M | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.3M | — | ||
| Q3 25 | $27.8M | — | ||
| Q2 25 | $28.1M | — | ||
| Q1 25 | $33.4M | $67.8M | ||
| Q4 24 | $32.1M | $101.2M | ||
| Q3 24 | $33.2M | $78.0M | ||
| Q2 24 | $39.5M | $185.3M | ||
| Q1 24 | $38.8M | $68.4M |
| Q4 25 | $41.5M | — | ||
| Q3 25 | $47.2M | — | ||
| Q2 25 | $49.8M | — | ||
| Q1 25 | $58.1M | $417.3M | ||
| Q4 24 | $57.8M | $428.7M | ||
| Q3 24 | $62.2M | $422.4M | ||
| Q2 24 | $64.8M | $429.9M | ||
| Q1 24 | $67.0M | $269.4M |
| Q4 25 | $75.7M | — | ||
| Q3 25 | $74.7M | — | ||
| Q2 25 | $78.7M | — | ||
| Q1 25 | $85.3M | $486.5M | ||
| Q4 24 | $86.2M | $526.3M | ||
| Q3 24 | $87.6M | $554.6M | ||
| Q2 24 | $90.9M | $582.0M | ||
| Q1 24 | $94.6M | $510.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.0M | $-38.5M |
| Free Cash FlowOCF − Capex | $3.9M | $-39.7M |
| FCF MarginFCF / Revenue | 20.5% | -192.9% |
| Capex IntensityCapex / Revenue | 0.1% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.0M | — | ||
| Q3 25 | $4.4M | — | ||
| Q2 25 | $2.8M | — | ||
| Q1 25 | $1.9M | $-38.5M | ||
| Q4 24 | $3.0M | $-31.6M | ||
| Q3 24 | $2.3M | $-24.3M | ||
| Q2 24 | $2.2M | $39.8M | ||
| Q1 24 | $666.0K | $-25.5M |
| Q4 25 | $3.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.8M | $-39.7M | ||
| Q4 24 | — | $-32.2M | ||
| Q3 24 | — | $-24.9M | ||
| Q2 24 | — | $38.8M | ||
| Q1 24 | — | $-26.4M |
| Q4 25 | 20.5% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 12.2% | -192.9% | ||
| Q4 24 | — | -86.2% | ||
| Q3 24 | — | -127.3% | ||
| Q2 24 | — | 41.0% | ||
| Q1 24 | — | -44.6% |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.5% | 5.6% | ||
| Q4 24 | 0.0% | 1.7% | ||
| Q3 24 | 0.0% | 3.3% | ||
| Q2 24 | 0.0% | 1.1% | ||
| Q1 24 | 0.0% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.56× | — | ||
| Q1 25 | 6.03× | — | ||
| Q4 24 | — | -27.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
